Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 2, 2000
Issued Date -
N/A
app pub date -
Jan 4, 1999
filing date -
May 22, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention describes a novel treatment for movement disorders, including tardive dyskinesia and tardive dystonia, and focal dystonias not due to neuroleptics, including blepharospasm, Meige syndrome, and occupational dystonias. The treatment of the present invention utilizes agents that act as NMDA-type glutamate receptor antagonists The invention also involves the use of an ion channel blocking agent to augment the therapeutic action of the drug treatments described. A particularly preferred ion channel blocking agent is magnesium.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully